Related Experiment Video
Updated: Sep 9, 2025

Phospholipid Mediator Induced Transformation in Three-Dimensional Cultures
Published on: July 27, 2022
Pannexin channels in inflammation and tumorigenesis
Mengmeng Jiang1,2, Xiaojia Li1,2, Keping Xie1,2
1Center for Pancreatic Cancer Research, The South China University of Technology School of Medicine, Guangzhou, China.
Abstract:
Pannexin (Panx) channels are oligomeric heptamers of PANX proteins, comprising Panx1, Panx2 and Panx3. These channels facilitate the extracellular release of signaling molecules up to 1.5 kDa in size, including adenosine triphosphate (ATP), amino acids, ions, and other metabolites. These signaling molecules can activate receptors either on their cells of origin or neighboring cells, triggering downstream signaling cascades that mediate various physiological responses. Current pharmacological inhibitors of Panx channels include Food and Drug Administration (FDA)-approved drugs such as Carbenoxolone (CBX), Probenecid (PBN), and Spironolactone, along with chemically synthetic compounds 10Panx. Both genetic modulation of Panx expression and pharmacological manipulation have demonstrated the channels' critical involvement in various human pathologies, establishing them as promising therapeutic targets for clinical intervention. In this review, we will specifically examine the signaling regulatory functions of Panx channels in the processes of inflammation and tumorigenesis; systematically evaluate the therapeutic potential of Panx inhibitors in these pathological contexts, critically analyze current research limitations, and strategically propose future perspectives in Panx channels and its inhibitors research.
Insights
Pannexin (Panx) channels regulate cell signaling by releasing molecules like ATP. Inhibiting these channels shows therapeutic potential for inflammation and cancer, despite current research limitations.
Area of Science:
- Cellular biology
- Molecular signaling
- Biochemistry
Background:
- Pannexin (Panx) channels are protein oligomers (Panx1, Panx2, Panx3) facilitating the release of signaling molecules up to 1.5 kDa.
- Released molecules like ATP and amino acids activate receptors, mediating physiological responses.
- Panx channels are implicated in various human pathologies, making them therapeutic targets.
Purpose of the Study:
- To review the signaling roles of Panx channels in inflammation and tumorigenesis.
- To evaluate the therapeutic potential of Panx inhibitors in these diseases.
- To analyze current research limitations and propose future directions.
Main Methods:
- Literature review of studies on Panx channel function and inhibition.
- Analysis of genetic and pharmacological approaches targeting Panx channels.
- Evaluation of Panx inhibitors in the context of inflammation and cancer.
Main Results:
- Panx channels play critical roles in inflammatory and tumorigenesis signaling pathways.
- FDA-approved drugs (e.g., Carbenoxolone) and synthetic compounds show inhibitory effects.
- Genetic and pharmacological studies confirm Panx channels' involvement in pathologies.
Conclusions:
- Panx channels are significant regulators of inflammation and cancer.
- Panx inhibitors represent a promising therapeutic strategy.
- Further research is needed to overcome limitations and optimize therapeutic use.
Related Concept Videos
Cadherins in Tissue Organization
Cell Sorting During Development
Cell sorting plays an...
Role of Ephrin-Eph Signalling in Intestinal Stem Cell Renewal
The Tumor Microenvironment
Intracellular Signaling Affects Focal Adhesions
Some...
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
NF-κB-dependent Signaling Pathway
NF-κB-dependent Signaling Mechanism
The...

